CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive

Sun,Mao; Zhou,Wei; Zhang,Yun‑Yun; Wang,Dong‑Lin; Wu,Xiao‑Ling

doi:10.3892/ol.2013.1272

CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive

Authors:
- Mao Sun
- Wei Zhou
- Yun‑Yun Zhang
- Dong‑Lin Wang
- Xiao‑Ling Wu
View Affiliations

Affiliations: Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China, Department of Radiology, Chongqing Cancer Hospital, Chongqing 400011. P.R. China, Departments of Oncology, Chongqing Cancer Hospital, Chongqing 400011. P.R. China
Published online on: March 26, 2013 https://doi.org/10.3892/ol.2013.1272
Pages: 1793-1798

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

CD44 has been confirmed as a cancer stem cell marker in a variety of human cancer cell lines and primary tumours, but whether this marker is applicable to gastric cancer (GC) remains unknown. The responses of CD44+ GC stem‑like cells to chemoradiation and the roles they play in cancer invasion are not well understood. In the present study, cell sorting was applied to the poorly differentiated human GC cells to isolate a pure concentration of the CD44+ cell populations (<1% CD44‑ cells). The stemness properties of the CD44+ cell population were confirmed by two ‘gold standard’ methods; an in vivo tumourigenicity assay and an in vitro spheroid colony formation assay. In addition, the treatment response was evaluated in CD44+ and CD44‑ cell fractions that underwent chemoradiation. In general, CD44+ stem‑like cells tended to respond more poorly to chemoradiation than their non‑stem-like counterparts. Further experimentation revealed that the CD44+ stem‑like cells that recorded positive scores in the migration and invasion assay in vitro formed invasive tumours in vivo. Therefore, we hypothesized that CD44+ stem‑like cells may significantly express invasion‑associated genes. Consistent with this prediction, increased expression of the cancer invasion‑related genes matrix metalloproteinase (MMP)‑1, MMP‑2, epidermal growth factor receptor (EGFR) and cyclooxygenase 2 (COX‑2) were detected in the CD44+ stem‑like cells. To the best of our knowledge, this is the first study that reveals the correlation between CD44+ GC cells and cancer invasion. By selectively eliminating CD44+ stem‑like cells, it may be possible to treat patients with aggressive, non‑resectable GCs, as well as preventing the tumours from metastasizing.

View Figures

View References

1	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
2	Yeh JM, Kuntz KM, Ezzati M, Hur C, Kong CY and Goldie SJ: Development of an empirically calibrated model of gastric cancer in two high-risk countries. Cancer Epidemiol Biomarkers Prev. 17:1179–1187. 2008. View Article : Google Scholar : PubMed/NCBI
3	Remesh A: Toxicities of anticancer drugs and its management. Int J Basic Clin Pharmacol. 1:2–12. 2012. View Article : Google Scholar
4	Dick JE: Stem cell concepts renew cancer research. Blood. 112:4793–4807. 2008. View Article : Google Scholar : PubMed/NCBI
5	Ward RJ and Dirks PB: Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol. 2:175–189. 2007. View Article : Google Scholar : PubMed/NCBI
6	Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006. View Article : Google Scholar
7	Takaishi S, Okumura T, Tu S, et al: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
8	Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and Le AD: A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
9	Tomuleasa C, Soritau O, Kacso G, et al: Arsenic trioxide sensitizes cancer stem cells to chemoradiotherapy. A new approach in the treatment of inoperable glioblastoma multiforme. J BUON. 15:758–762. 2010.PubMed/NCBI
10	Guddati AK: Ovarian cancer stem cells: elusive targets for chemotherapy. Med Oncol. 29:3400–3408. 2012. View Article : Google Scholar : PubMed/NCBI
11	Du Z, Qin R, Wei C, et al: Pancreatic cancer cells resistant to chemoradiotherapy rich in ‘stem-cell-like’ tumor cells. Dig Dis Sci. 56:741–750. 2011.PubMed/NCBI
12	Croker AK and Allan AL: Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells. Breast Cancer Res Treat. 133:75–87. 2012. View Article : Google Scholar : PubMed/NCBI
13	Albright N: Computer programs for the analysis of cellular survival data. Radiat Res. 112:331–340. 1987. View Article : Google Scholar : PubMed/NCBI
14	Olive PL, Banáth JP and Durand RE: Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the ‘comet’ assay. 1990. Radiat Res. 178:AV35–AV42. 2012.
15	Shankar S, Nall D, Tang SN, et al: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One. 6:e165302011. View Article : Google Scholar
16	Walter D, Satheesha S, Albrecht P, et al CWS Study Group: CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS One. 6:e195062011. View Article : Google Scholar : PubMed/NCBI
17	Zhou J, Wang H, Cannon V, Wolcott KM, Song H and Yates C: Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Mol Cancer. 10:1122011.
18	Patrawala L, Calhoun T, Schneider-Broussard R, et al: Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 25:1696–1708. 2006.
19	England K, Driscoll CO and Cotter TG: ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis. Free Radic Res. 40:1124–1137. 2006. View Article : Google Scholar : PubMed/NCBI
20	Gupta GP, Nguyen DX, Chiang AC, et al: Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature. 446:765–770. 2007. View Article : Google Scholar : PubMed/NCBI
21	Chen MS, Woodward WA, Behbod F, et al: Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci. 120:468–477. 2007.PubMed/NCBI
22	Song Z, Yue W, Wei B, et al: Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. PLoS One. 6:e176872011. View Article : Google Scholar : PubMed/NCBI
23	Dalerba P, Dylla SJ, Park IK, et al: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
24	Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
25	Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
26	Chen T, Yang K, Yu J, et al: Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res. 22:248–258. 2012. View Article : Google Scholar : PubMed/NCBI
27	Zetter BR: Angiogenesis and tumor metastasis. Annu Rev Med. 49:407–424. 1998. View Article : Google Scholar : PubMed/NCBI
28	Yu Q and Stamenkovic I: Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13:35–48. 1999. View Article : Google Scholar : PubMed/NCBI
29	Pongcharoen P, Jinawath A and Tohtong R: Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells. Clin Exp Metastasis. 28:827–839. 2011. View Article : Google Scholar : PubMed/NCBI
30	Ishimoto T, Oshima H, Oshima M, et al: CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci. 101:673–678. 2010.